51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-001353-28-IT (EUCTR)	04/10/2013	04/07/2013	An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone when Administ ...	An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone when Administ ...	Systemic Sclerosis-Related Interstitial Lung Disease;Therapeutic area: Diseases [C] - Respiratory Tr ...	Trade Name: Esbriet INN or Proposed INN: PIRFENIDONE	InterMune Inc.	NULL	Not Recruiting			Female: yes Male: yes	50	Phase 2	United States;Canada;Italy

First Previous1Next Last